B0RN79 AF NFT

Bifunctional glutamine synthetase adenylyltransferase/adenylyl-removing enzyme

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigim73kjhldb4vutovi47gqdak4gdqzzt7eq7gatnlyi6dqa6nyhi/metadata.json
IPFS of structure file: 
bafybeidzt7c3sg7oo26rqkmf6yvg2lm3gkimsqmv4b63vocgxffgvssiku/AF-B0RN79-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x83F786ce01f5479fe16b8Cc8921aa2b71C99D1C9
First NFT owner address (bech32): 
genesis1s0mcdnsp74relctt3nyfyx4zkuwfn5wfl45cr6
Current NFT ID #151303 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
151303
Accession (UniProt):
B0RN79
Name::
Bifunctional glutamine synthetase adenylyltransferase/adenylyl-removing enzyme
Experimental Method:
Predicted structure
Sequence source:
XANTHOMONAS CAMPESTRIS PV. CAMPESTRIS (STRAIN B100)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B0RN79 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B0RN79|GLNE_XANCB Bifunctional glutamine synthetase adenylyltransferase/adenylyl-removing enzyme OS=Xanthomonas campestris pv. campestris (strain B100) OX=509169 GN=glnE PE=3 SV=1 MSQPIPSASPALAALIERAVARVRHALPADAPWPEGLEHPLARVALASDFVVDTLARQPALLAHLAQPDPPPLPVPRLDPAQPQEWAAQLRRYRAAASARLVWRDVLGLDDVDATLAGATMLAETCLQCALQALEQQFATRHGQVIAEDGSVQRLVVFGLGKLGGGELNFSSDVDLVYAYPQAGQSDGARPLAAEEYFARLGQQLAKLLDETTADGFSHRVDLRLRPFGSAGRVALSFNGMDQYFQREGRDWERYAWLKARPVAGDIAAGEAWLETLRPFVYRRYLDFTALDGLRDMKAAITAEVARHARLDDIKRGPGGIREIEFLVQSLQLIRGGREASLRERRLLPALQALVDLGQIDPPTGQALAEAYRFLRRVENRLQMLRDAQTHALPQGEPERERIALGLGYAHWQALLEALAPHRTRVAAEFAELLAPRVHATAPDTLADYWRALPEGDAAPLLGIGLHDPNNAHHMLADFAQSSGVRALSDGARTRLDRVMPALLHAAIRATQPDAALRRVLGLLQATLRRTSYLALLDEQPSALARLVDVLSRSALLAERLAAYPLLLDELLDTRISGPLPDRAALHTACVDTLQIDDTEAALRELNERRLALSFRIALATLDGRQQPVDSTQQLAWLAEAVVQTVLQLAQTQLQAAHGQVPGGAFAIIGYGSLGGMELGFGSDLDLVFLYDHPREVEASDGKRPLEAGRWFARLAQKVMTLLGAETGAGRLYDIDVRLRPDGGKGALVSSLASYRDYQRDRAWTWEHQALVRARAVAGDAALCEAFVQVRRETLTRVRDPALLHEDVRKMRARMRSELDRSDAGRLDLKQGAGGLVDLEFLLQAGVLGQAAQHPALLLACATPALIDALVQVQWLPAESAAPLHHAHATLVEAGLSCTLDRRPRLVVSTPPIRDACQIVAAIADAQQLRFQPGKGA